Complementary animal experiments reinforced the significant role of Ruthenibacterium lactatiformans and ILA in mitigating obesity, glucose intolerance, and dyslipidemia induced by a high-fat diet (HFD). Here, TNFRSF9 is linked to Glucose intolerance.